154 related articles for article (PubMed ID: 29168600)
1. Molecular characterization of Helicobacter pylori resistance to rifamycins.
Hays C; Burucoa C; Lehours P; Tran CT; Leleu A; Raymond J
Helicobacter; 2018 Feb; 23(1):. PubMed ID: 29168600
[TBL] [Abstract][Full Text] [Related]
2. Characterization of rifampicin-resistant clinical Helicobacter pylori isolates from Germany.
Glocker E; Bogdan C; Kist M
J Antimicrob Chemother; 2007 May; 59(5):874-9. PubMed ID: 17350989
[TBL] [Abstract][Full Text] [Related]
3. Past rifampicin dosing determines rifabutin resistance of Helicobacter pylori.
Suzuki S; Suzuki H; Nishizawa T; Kaneko F; Ootani S; Muraoka H; Saito Y; Kobayashi I; Hibi T
Digestion; 2009; 79(1):1-4. PubMed ID: 19142036
[TBL] [Abstract][Full Text] [Related]
4. In-vitro activity of rifabutin against rifampicin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations.
Cavusoglu C; Karaca-Derici Y; Bilgic A
Clin Microbiol Infect; 2004 Jul; 10(7):662-5. PubMed ID: 15214882
[TBL] [Abstract][Full Text] [Related]
5. Effective therapeutic regimens in two South Asian countries with high resistance to major
Miftahussurur M; Aftab H; Shrestha PK; Sharma RP; Subsomwong P; Waskito LA; Doohan D; Fauzia KA; Yamaoka Y
Antimicrob Resist Infect Control; 2019; 8():40. PubMed ID: 30815255
[TBL] [Abstract][Full Text] [Related]
6. Mutations at four distinct regions of the rpoB gene can reduce the susceptibility of Helicobacter pylori to rifamycins.
Heep M; Odenbreit S; Beck D; Decker J; Prohaska E; Rieger U; Lehn N
Antimicrob Agents Chemother; 2000 Jun; 44(6):1713-5. PubMed ID: 10817737
[TBL] [Abstract][Full Text] [Related]
7. Relationship between antimycobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis.
Yang B; Koga H; Ohno H; Ogawa K; Fukuda M; Hirakata Y; Maesaki S; Tomono K; Tashiro T; Kohno S
J Antimicrob Chemother; 1998 Nov; 42(5):621-8. PubMed ID: 9848446
[TBL] [Abstract][Full Text] [Related]
8. Emerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal.
Miftahussurur M; Shrestha PK; Subsomwong P; Sharma RP; Yamaoka Y
BMC Microbiol; 2016 Nov; 16(1):256. PubMed ID: 27809767
[TBL] [Abstract][Full Text] [Related]
9. Rifampicin- and Rifabutin-Resistant Listeria monocytogenes Strains Isolated from Food Products Carry Mutations in rpoB Gene.
Korsak D; Krawczyk-Balska A
Foodborne Pathog Dis; 2016 Jul; 13(7):363-8. PubMed ID: 27105395
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of the antimycobacterial activities of rifabutin and the relationship between drug-resistance and rpoB mutations of Mycobacterium tuberculosis].
Han XQ; Huang HR; Li YJ; Yu X; Gao JT; Bi ZQ; Chu NH; Li L; Ma Y
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Oct; 34(10):762-5. PubMed ID: 22321711
[TBL] [Abstract][Full Text] [Related]
11. Rifampicin-resistant and rifabutin-susceptible Mycobacterium tuberculosis strains: a breakpoint artefact?
Schön T; Juréen P; Chryssanthou E; Giske CG; Kahlmeter G; Hoffner S; Angeby K
J Antimicrob Chemother; 2013 Sep; 68(9):2074-7. PubMed ID: 23633684
[TBL] [Abstract][Full Text] [Related]
12. Detection of rifabutin resistance and association of rpoB mutations with resistance to four rifamycin derivatives in Helicobacter pylori.
Heep M; Lehn N; Brandstätter B; Rieger U; Senzenberger S; Wehrl W
Eur J Clin Microbiol Infect Dis; 2002 Feb; 21(2):143-5. PubMed ID: 11939398
[No Abstract] [Full Text] [Related]
13. Frequency and molecular characteristics of ciprofloxacin- and rifampicin-resistant Helicobacter pylori from gastric infections in the UK.
Chisholm SA; Owen RJ
J Med Microbiol; 2009 Oct; 58(Pt 10):1322-1328. PubMed ID: 19589906
[TBL] [Abstract][Full Text] [Related]
14. Rifampin and rifabutin resistance mechanism in Helicobacter pylori.
Heep M; Beck D; Bayerdörffer E; Lehn N
Antimicrob Agents Chemother; 1999 Jun; 43(6):1497-9. PubMed ID: 10348780
[TBL] [Abstract][Full Text] [Related]
15. The Inappropriateness of Using Rifampicin E-Test to Predict Rifabutin Resistance in Helicobacter pylori.
Yang T; Liu B; Zhou J; Shen Y; Song X; Tang X; Benghezal M; Marshall BJ; Tang H; Li H
J Infect Dis; 2022 Dec; 226(Suppl 5):S479-S485. PubMed ID: 36478247
[TBL] [Abstract][Full Text] [Related]
16. [Prevalence and mechanism of Helicobacter pylori resistance to clarithromycin in children].
Chen J; Yu JD; Huang XL; Chen FB; Li ZY; Zhang XP
Zhonghua Er Ke Za Zhi; 2004 Nov; 42(11):850-3. PubMed ID: 15631715
[TBL] [Abstract][Full Text] [Related]
17. Identification and molecular characterization of triple- and quadruple-resistant Helicobacter pylori clinical isolates in Germany.
Wueppenhorst N; Stueger HP; Kist M; Glocker E
J Antimicrob Chemother; 2009 Apr; 63(4):648-53. PubMed ID: 19190100
[TBL] [Abstract][Full Text] [Related]
18. PCR-RFLP detection of point mutations A2143G and A2142G in 23S rRNA gene conferring resistance to clarithromycin in Helicobacter pylori strains.
Klesiewicz K; Nowak P; Karczewska E; Skiba I; Wojtas-Bonior I; Sito E; Budak A
Acta Biochim Pol; 2014; 61(2):311-5. PubMed ID: 24927236
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of rifabutin-resistance in refractory Helicobacter pylori infection in Taiwan.
Kuo CJ; Bui NN; Ke JN; Lin CY; Lin WR; Chang ML; Wu HY; Huang MZ; Chiu CH; Chiu CT; Lai CH
Int J Infect Dis; 2024 Jan; 138():25-28. PubMed ID: 37956898
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of detection of clarithromycin-resistant Helicobacter pylori from fecal specimens for young adults treated with eradication therapy.
Osaki T; Mabe K; Zaman C; Yonezawa H; Okuda M; Amagai K; Fujieda S; Goto M; Shibata W; Kato M; Kamiya S
Helicobacter; 2017 Oct; 22(5):. PubMed ID: 28544222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
